Chemogenomic profiling predicts antifungal synergies
Abstract Chemotherapies, HIV infections, and treatments to block organ transplant rejection are creating a population of immunocompromised individuals at serious risk of systemic fungal infections. Since single‐agent therapies are susceptible to failure due to either inherent or acquired resistance,...
Saved in:
| Main Authors: | Gregor Jansen, Anna Y Lee, Elias Epp, Amélie Fredette, Jamie Surprenant, Doreen Harcus, Michelle Scott, Elaine Tan, Tamiko Nishimura, Malcolm Whiteway, Michael Hallett, David Y Thomas |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2009-12-01
|
| Series: | Molecular Systems Biology |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/msb.2009.95 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antifungal Activity of Selected Naphthoquinones and Their Synergistic Combination with Amphotericin B Against <i>Cryptococcus neoformans</i> H99
by: Naira Sulany Oliveira de Sousa, et al.
Published: (2025-06-01) -
Synergistic Antifungal Efficacy of Eugenol‐Loaded Nanocapsules Combined With Itraconazole Against Trichophyton mentagrophytes
by: Javad Malakootikhah, et al.
Published: (2025-05-01) -
Reverse genetics in Candida albicans predicts ARF cycling is essential for drug resistance and virulence.
by: Elias Epp, et al.
Published: (2010-02-01) -
The evolution of antifungal therapy: Traditional agents, current challenges and future perspectives
by: Cássia Milena de Souza, et al.
Published: (2025-01-01) -
Global onychomycosis management and the challenges of antifungal stewardship
by: Aditya K. Gupta, et al.
Published: (2025-12-01)